D.T. Byng MSc (Danalyn)

Byng, D., Thomas, S. M., Rushing, C. N., Lynch, T., McCarthy, A., Francescatti, A. B., Frank, E. S., Partridge, A. H., Thompson, A. M. , Retèl, V. P. , van Harten, W. H., Grimm, L. J., Hyslop, T., Hwang, E. S., & Ryser, M. D. (2023). Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ. Radiology, 307(1), e221210. Article e221210. https://doi.org/10.1148/radiol.221210

Byng, D. T. (2022). ‘One size does not fit all’: Translational health technology assessment in early breast cancer and DCIS. [PhD Thesis - Research external, graduation UT, University of Twente]. University of Twente. https://doi.org/10.3990/1.9789036554336

Grand Challenge Precision Consortium (2021). Preferences of treatment strategies among women with low-risk dcis and oncologists. Cancers, 13(16), Article 3962. https://doi.org/10.3390/cancers13163962

on behalf of the Grand Challenge PRECISION consortium (2021). Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence? Breast cancer research and treatment, 187(1), 187-196. https://doi.org/10.1007/s10549-020-06042-1

Grand Challenge Precision Consortium (2020). Non-intervention vs. surgical interventions in (Low-Risk) Ductal Carcinoma In Situ: A DCIS multi-state model for decision analytics. European journal of cancer, 138(Suppl. 1), S25. https://doi.org/10.1016/S0959-8049(20)30584-0

Retèl, V. P. , Byng, D., Linn, S. C., Jóźwiak, K. , Koffijberg, H., Rutgers, E. J., Cardoso, F., Piccart, M. J., Poncet, C., van 't Veer, L. J. , & van Harten, W. H. (2020). Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial. European journal of cancer, 137, 193-203. https://doi.org/10.1016/j.ejca.2020.07.002